About Index Trending news
Analyze
Pricing
Nektar Therapeutics

Nektar Therapeutics

Work at Nektar Therapeutics? Add yourself to this profile

Nektar Therapeutics

Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.
Edit Profile
More info

Elsewhere

Also headquartered in San Francisco

Twitter Twitter Uber Uber Instagram Instagram Airbnb Airbnb Lyft Lyft Reddit Reddit Salesforce Salesforce Fitbit Fitbit TechCrunch TechCrunch Slack Slack

Companies in the same industry

23andMe 23andMe Blue Belt Technologies Blue Belt Technologies Health IQ Health IQ Adaptive Biotech Adaptive Biotech Gecko Biomedical Gecko Biomedical Eccrine Systems Eccrine Systems NuSirt Sciences, Inc NuSirt Sciences, Inc Synchro PET Synchro PET Inspyr Inspyr Essia Health Essia Health

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Investments 1
Add info
Latest funding
Post-IPO equity
$20,000,000
Venture capital
$25,000,000
AstraZeneca
Employees

Team size

500+
Locations
HQ
San Francisco, United States
Headquarters
$20,000,000 Post-IPO equity
Xconomy

Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug

Health
Nektar Therapeutics
Nektar Therapeutics
The Motley Fool

Why Nektar Therapeutics Inc Is Dropping Today

Nektar Therapeutics
Nektar Therapeutics
The Motley Fool

Here's Why Nektar Therapeutics Inc. Rose 19% in March

Nektar Therapeutics
Nektar Therapeutics
The Motley Fool

Why Nektar Therapeutics Skyrocketed 30% Higher in October --

Stock markets Health
Nektar Therapeutics
Nektar Therapeutics